image

SEC Filing Details

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
SEC Filing Details

Document Details

Filing Date
April 29, 2021
Document Date
June 18, 2021
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Prelude Therapeutics
Issuer
PRELUDE THERAPEUTICS INC